Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...
With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...
Diet and physical activity are primary treatments for MAFLD, as per new guidelines. Regular aerobic exercise and weight loss are crucial in reducing liver fat, with a Mediterranean diet offering ...
March 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced new 'in ...
Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, ...
Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD) ...
Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...
At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a ...
Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback